Author:
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 218
Book Description
National Drug Control Strategy
Author:
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 218
Book Description
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 218
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Treating Drug Problems:
Author: Committee for the Substance Abuse Coverage Study
Publisher: National Academies Press
ISBN: 9780309043960
Category : Medical
Languages : en
Pages : 332
Book Description
Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.
Publisher: National Academies Press
ISBN: 9780309043960
Category : Medical
Languages : en
Pages : 332
Book Description
Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.
Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence
Author: World Health Organization. Department of Mental Health and Substance Abuse
Publisher: World Health Organization
ISBN: 9241547545
Category : Medical
Languages : en
Pages : 133
Book Description
"These guidelines were produced by the World Health Organization (WHO), Department of Mental Health and Substance Abuse, in collaboration with the United Nations Office on Drugs and Crime (UNODC) a Guidelines Development Group of technical experts, and in consultation with the International Narcotics Control Board (INCB) secretariat and other WHO departments. WHO also wishes to acknowledge the financial contribution of UNODC and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to this project. " - p. iv
Publisher: World Health Organization
ISBN: 9241547545
Category : Medical
Languages : en
Pages : 133
Book Description
"These guidelines were produced by the World Health Organization (WHO), Department of Mental Health and Substance Abuse, in collaboration with the United Nations Office on Drugs and Crime (UNODC) a Guidelines Development Group of technical experts, and in consultation with the International Narcotics Control Board (INCB) secretariat and other WHO departments. WHO also wishes to acknowledge the financial contribution of UNODC and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to this project. " - p. iv
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
International Drug Control
Author: David R. Bewley-Taylor
Publisher: Cambridge University Press
ISBN: 1107014972
Category : Law
Languages : en
Pages : 361
Book Description
The first integrated analysis of the causes and effects of diverging views of drug use within the international community.
Publisher: Cambridge University Press
ISBN: 1107014972
Category : Law
Languages : en
Pages : 361
Book Description
The first integrated analysis of the causes and effects of diverging views of drug use within the international community.
The Role of NIH in Drug Development Innovation and Its Impact on Patient Access
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309498511
Category : Medical
Languages : en
Pages : 103
Book Description
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Publisher: National Academies Press
ISBN: 0309498511
Category : Medical
Languages : en
Pages : 103
Book Description
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
The National Drug Control Strategy
Author: United States. Congress. House. Committee on Government Operations. Legislation and National Security Subcommittee
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages :
Book Description
NarcoDiplomacy
Author: H. Richard Friman
Publisher: Cornell University Press
ISBN: 9780801432743
Category : History
Languages : en
Pages : 204
Book Description
If illicit drug trafficking is a global problem, why won't other nations comply with the drug control agenda of the United States? NarcoDiplomacy departs from traditional responses to this question, which have held that compliance with the American agenda has been beyond the capacity of key countries. By focusing on Germany and Japan, touted as two of the strongest allies of the United States in drug control efforts, H. Richard Friman exposes the flaws in capacity arguments and the policies based on them. Drawing on sources ranging from previously unknown Imperial German archives to interviews with policy makers and law enforcement officials, Friman offers a thorough analysis of bilateral and multilateral relations. He traces their evolution from international opium control efforts of the early 1900s through disputes over cocaine and money laundering during the Reagan and Bush antidrug campaigns. His work reveals that, although the internal logic of the U.S. posture was sound, American policy makers failed to recognize the nature of German and Japanese cooperation and defection, or to identify which aspects of capacity were at issue. The resulting policy, Friman contends, actually undermined German and Japanese compliance with the American agenda. Extending this analysis to Latin America, NarcoDiplomacy explores the ramifications of Friman's findings for the future of U.S. drug control policy.
Publisher: Cornell University Press
ISBN: 9780801432743
Category : History
Languages : en
Pages : 204
Book Description
If illicit drug trafficking is a global problem, why won't other nations comply with the drug control agenda of the United States? NarcoDiplomacy departs from traditional responses to this question, which have held that compliance with the American agenda has been beyond the capacity of key countries. By focusing on Germany and Japan, touted as two of the strongest allies of the United States in drug control efforts, H. Richard Friman exposes the flaws in capacity arguments and the policies based on them. Drawing on sources ranging from previously unknown Imperial German archives to interviews with policy makers and law enforcement officials, Friman offers a thorough analysis of bilateral and multilateral relations. He traces their evolution from international opium control efforts of the early 1900s through disputes over cocaine and money laundering during the Reagan and Bush antidrug campaigns. His work reveals that, although the internal logic of the U.S. posture was sound, American policy makers failed to recognize the nature of German and Japanese cooperation and defection, or to identify which aspects of capacity were at issue. The resulting policy, Friman contends, actually undermined German and Japanese compliance with the American agenda. Extending this analysis to Latin America, NarcoDiplomacy explores the ramifications of Friman's findings for the future of U.S. drug control policy.
National Drug Control Strategy (1997)
Author: Barry R. McCaffrey
Publisher: DIANE Publishing
ISBN: 9780788139949
Category : Political Science
Languages : en
Pages : 80
Book Description
Contents: the purposes and nature of strategy (a comprehensive 10-year plan); profile of drug abusers (trends in youth drug abuse; health consequences; cost of drug-related crime; illegal drugs remain available); strategic goals and objectives (demand and supply reduction; goals and objectives; measures of effectiveness); a comprehensive approach (youth oriented initiatives; initiatives to reduce drug-related crime and violence; reduce health and social problems; shield our frontiers; reduce drug availability); and resources to implement the strategy.
Publisher: DIANE Publishing
ISBN: 9780788139949
Category : Political Science
Languages : en
Pages : 80
Book Description
Contents: the purposes and nature of strategy (a comprehensive 10-year plan); profile of drug abusers (trends in youth drug abuse; health consequences; cost of drug-related crime; illegal drugs remain available); strategic goals and objectives (demand and supply reduction; goals and objectives; measures of effectiveness); a comprehensive approach (youth oriented initiatives; initiatives to reduce drug-related crime and violence; reduce health and social problems; shield our frontiers; reduce drug availability); and resources to implement the strategy.